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A B S T R A C T
Aging is characterized by increased aortic stiffness, an early, independent predictor and cause of cardiovascular disease. Oxidative stress from excess reactive oxygen
species (ROS) production increases with age. Mitochondria and NADPH oxidases (NOXs) are two major sources of ROS in cardiovascular system. We showed
previously that increased mitochondrial ROS levels over a lifetime induce aortic stiffening in a mouse oxidative stress model. Also, NADPH oxidase 4 (NOX4)
expression and ROS levels increase with age in aortas, aortic vascular smooth muscle cells (VSMCs) and mitochondria, and are correlated with age-associated aortic
stiffness in hypercholesterolemic mice. The present study investigated whether young mice (4 months-old) with increased mitochondrial NOX4 levels recapitulate
vascular aging and age-associated aortic stiffness. We generated transgenic mice with low (Nox4TG605; 2.1-fold higher) and high (Nox4TG618; 4.9-fold higher)
mitochondrial NOX4 expression. Young Nox4TG618 mice showed significant increase in aortic stiffness and decrease in phenylephrine-induced aortic contraction,
but not Nox4TG605 mice. Increased mitochondrial oxidative stress increased intrinsic VSMC stiffness, induced aortic extracellular matrix remodeling and fibrosis, a
leftward shift in stress-strain curves, decreased volume compliance and focal adhesion turnover in Nox4TG618 mice. Nox4TG618 VSMCs phenocopied other features
of vascular aging such as increased DNA damage, increased premature and replicative senescence and apoptosis, increased proinflammatory protein expression and
decreased respiration. Aortic stiffening in young Nox4TG618 mice was significantly blunted with mitochondrial-targeted catalase overexpression. This demonstration
of the role of mitochondrial oxidative stress in aortic stiffness will galvanize search for new mitochondrial-targeted therapeutics for treatment of age-associated
vascular dysfunction.
Oxidative stress, mitochondrial dysfunction and aging are asso-
ciated with the pathogenesis of cardiovascular diseases [1]. The two
major reactive oxygen species (ROS) generating sources within cells are
mitochondria and nicotinamide adenine dinucleotide phosphate
(NADPH) oxidases (NOXs) [2,3]. Mitochondria generate ROS as a by-
product of oxidative phosphorylation, while the major function of
NADPH oxidases is generation of ROS. The NOX family members in-
clude NOX1-5 and DUOX1-2 isoforms [4]. Transmembrane NOX1,
NOX2, NOX4, and NOX5 catalytic subunits are expressed in vascular
tissue; however, NOX5 is absent in rodents [4]. All NOX subunits, with
the exception of NOX5, interact with another transmembrane protein,
p22phox, forming a membrane-bound catalytic core [5]. Unlike NOX1-
3, NOX4 does not require conventional cytosolic regulatory subunits for
activity, but DNA polymerase-δ-interacting protein 2 was shown to
stimulate NOX4 activity in vascular smooth muscle cells (VSMCs) [6].
NOX4 activity is regulated at the expression level in response to a wide
range of stimuli, generating predominantly H2O2, which can diffuse
through membranes and affect intra- and intercellular signaling path-
ways [7–9]. Furthermore, NOX4 localizes to mitochondria, increasing
mitochondrial ROS levels [10–12].
NOX4 is present in many cell types and is highly expressed in vas-
cular wall cells [13]; its expression and activity are significantly in-
creased in endothelial and smooth muscle cells in response to proin-
flammatory mediators and cytokines [14,15]. We recently showed that
NOX4 expression is increased in VSMC mitochondria and vasculature
and is associated with increased aortic stiffening and atherosclerosis in
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aged hypercholesterolemic mice [12]. Furthermore, increased NOX4
expression in arterial wall in humans is correlated with age and
atherosclerotic lesion severity [12,16].
Increased stiffness of large arteries, a major determinant of pulse
pressure, is a significant and independent predictor of adverse cardio-
vascular events [17]. Conducting arteries such as aorta and carotid
artery have large amount of elastin, allowing the vessel to expand and
recoil to dampen the oscillatory changes in blood pressure arising from
regular ventricular contractions [18]. The pressure waves, when
reaching vascular branch points, are reflected back to the heart. In
healthy individuals the reflected wave arrives during diastole, aiding in
coronary blood flow; however, in individuals with aortic stiffening the
pressure wave returns much quicker and arrives in systole, augmenting
the afterload, inducing left ventricular hypertrophy, and reducing cor-
onary blood flow. The resultant insufficiency in myocardial perfusion
may cause myocardial ischemia and heart failure [19]. Furthermore,
aortic stiffness is a precursor of hypertension [20].
Increased oxidative stress is implicated in decreased aortic com-
pliance in patients with coronary artery disease [21]. We and others
have shown that increased mitochondrial oxidative stress is a con-
tributing factor in age-associated arterial stiffening [12,22,23]. How-
ever, it is not known whether mitochondrial oxidative stress plays a
causative role in aortic stiffening. The present study was designed to
determine whether increasing mitochondrial ROS production in young
mice, by increasing NOX4 expression, would recapitulate the age-as-
sociated aortic stiffening observed by our laboratory and others. Our
data demonstrate that increased mitochondrial oxidative stress in
young mice induces aortic stiffening and VSMC phenotype similar to
that observed in aged mice. Specifically, decreased aortic compliance
with increased mitochondrial oxidative stress mainly results from
structural remodeling of the vascular wall mediated by VSMCs rather
than endothelial cells.
1. Results
Generation of Mitochondrial-specific Nox4 Transgenic Mice.
The function of NOX4 in the pathogenesis of cardiovascular disease
(CVD) is controversial. Some investigators reported that NOX4 provides
protection against atherosclerosis [24] and cardiac dysfunction in re-
sponse to pressure overload, particularly using young mice [25]. On the
other hand, we and others showed association of increased NOX4 ex-
pression/activity with atherosclerosis [15,16,26] and cardiomyocyte
hypertrophy, cell death, and cardiac fibrosis during pressure overload
[27] and in cardiac remodeling [28]. In contrast to a report that NOX4
protein was not detectable in cardiomyocyte mitochondria under phy-
siological conditions [29], at least 18 publications reported NOX4 lo-
calization to mitochondria in several cell types, including vascular cells,
under pathophysiological conditions (for example [10–12]). We pre-
viously showed increased mitochondrial NOX4 expression in the aortic
wall and VSMCs isolated from aortas with aging and its association with
aortic stiffening and atherosclerosis in hypercholesterolemic mice [12].
Therefore, to determine whether increased mitochondrial NOX4
expression has a causative role in aging-associated aortic stiffness, we
generated mitochondria-targeted Nox4 transgenic (Nox4TG) mice with
varying levels of Nox4 expression, using a plasmid construct containing
mouse Nox4 gene (Fig. 1A). Southern analysis of genomic DNA iden-
tified a lower (TG605) and a higher (TG618) Nox4 transgene containing
founders (Fig. 1B). Gene expression analysis, measured by q-PCR, in
VSMCs showed a 2-fold (Nox4TG605) and 20-fold (Nox4TG618) in-
crease in Nox4 mRNA levels relative to the wild-type (Fig. 1C). The
Nox4 expression in Nox4TG618 mice are in line with NOX4 expression
in aged human carotid arteries [12]. NOX4 protein expression in liver
mitochondria was increased 2.1- and 4.9-fold in Nox4TG605 and
Nox4TG618, respectively, compared with the wild-type (Fig. 1D). Fur-
ther supporting the increased NOX4 mitochondrial localization in
Nox4TG mice, a significant increase in yellow fluorescence was
observed in VSMC mitochondria from the colocalization of MitoTracker
Green FM and immunoreactive NOX4 (Fig. 1 E and F).
Nox4TG grew normally and did not show any gross phenotypic
abnormalities. Nox4TG mice were not different from wild-type litter-
mates in appearance, body weight (25.1 ± 0.76 vs 25.36 ± 1.15 g
(mean ± SEM) wild-type littermates, ~4 months-old), behavior or
fertility. The inheritance of Nox4TG allele in TG605 and TG618 mice
was approximately 50% in accordance with Mendelian ratios, sug-
gesting single chromosome integration of the transgene. Nox4 trans-
gene was expressed in all tissues studied. The expression of other
NADPH oxidases ̶ Nox1 and Nox2 ̶ was not affected by Nox4 transgene
expression (data not shown).
Young Nox4TG Mice Phenocopy Age-associated Aortic
Stiffening and Impaired Vasomotor Function. NOX4 is a critical
mediator of increased mitochondrial oxidative stress during aging [12]
and mitochondrial stress/dysfunction contributes to large elastic artery
stiffening and impaired contractile function [12,22,23,30]. To de-
termine whether young Nox4TG mice will recapitulate aging-associated
vascular dysfunction, we first measured pulse wave velocity (PWV).
Both young Nox4TG605 and TG618 mice (4 months-old) showed an
increase in PWV, but the difference was not significant between
Nox4TG605 and wild-type mice (Fig. 2A). However, PWV increased
4.5-fold in Nox4TG618 mice compared with age-matched wild-type
mice (Fig. 2A). PWV was also significantly higher in Nox4TG618 mice
compared with age-matched Nox4TG605 mice (P < 0.05). Vasomotor
function analysis of abdominal aortic rings by wire myography showed
a lower but not a significant decrease in phenylephrine-induced max-
imum contraction in Nox4TG605 (Fig. 2B) and a 57% decrease in
Nox4TG618 (Fig. 2C; P < 0.05) mice versus wild-type mice. Consistent
with this, dose response curve showed that the response to pheny-
lephrine was similar between wild-type and Nox4TG605 mice (Fig. 2D),
whereas Nox4TG618 mice showed impaired aortic contraction com-
pared with the wild-type mice (Fig. 2E; P < 0.05). However, en-
dothelium-dependent relaxation to acetylcholine after pre-contraction
with phenylephrine (SI Appendix, Fig. S1 A and B) and endothelium-
independent relaxation to sodium nitroprusside (Fig. S1 C and D) were
not affected in young Nox4TG mice.
We performed collagen gel contraction assay to determine whether
the decrease in maximum contractile force in response to pheny-
lephrine is partly contributed by NOX4-induced changes in the con-
tractile phenotype of aortic SMCs [31]. Gel contraction mediated by
aortic VSMCs from wild-type and Nox4TG605 was similar (Fig. 2 F and
G). In comparison, the reduction in gel contraction was significantly
attenuated with aortic VSMCs isolated from Nox4TG618 mice (Fig. 2 F
and G), indicating that increase in mitochondrial NOX4 expression le-
vels induces VSMC stiffening.
Increase in Intrinsic Stiffness of Aortic VSMCs Contributes to
Aortic Stiffening in Young Nox4 Transgenic Mice. To further explore
the underlying mechanism for the reduction in gel contraction observed
with Nox4TG618 VSMCs and also because aortic stiffness with aging is
attributed to intrinsic changes in VSMCs [32], we determined single
VSMC stiffness using atomic force microscopy. As shown in Fig. 3,
elastic modulus, a measure of stiffness, was significantly higher in
aortic VSMCs from young Nox4TG618 (21.0 ± 1.3 kPa, 10 cells, 150
measurements) compared with cells from young wild-type mice
(13.0 ± 0.66 kPa, 10 cells, 105 measurements), further supporting the
notion that mice with increased mitochondrial NOX4 expression phe-
nocopy vascular aging.
Increase in Mitochondrial NOX4 Expression Induces Age-asso-
ciated Extracellular Matrix Remodeling. Age-dependent increase in
aortic wall stiffness is attributed to extracellular remodeling, including
fibrosis [33] and we reported previously that treatment with mi-
tochondria-targeted antioxidant, MitoTEMPO, significantly lowers
aortic wall collagen content and pulse wave velocity (PWV) in mouse
models of atherosclerosis [12]. Hence, we first determined expression
of immunoreactive connective tissue growth factor (CTGF), an
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important regulator of fibrosis [34], in aortic cross sections. CTGF ex-
pression was significantly higher in the aortas of young Nox4TG mice
versus the wild-type and correlated with NOX4 levels (Fig. 4A). Con-
gruently, aortic wall collagen content was higher in young Nox4TG
mice versus the wild-type, with young Nox4TG618 mice showing a
significant increase (Fig. 4B).
To determine the clinical relevance of relationship between NOX4
expression and aging-associated arterial fibrosis, we examined NOX4,
CTGF, and collagen expression levels in the carotid artery cross sections
of young and older human subjects. Corroborating the data from our
mouse models, carotid artery wall NOX4, CTGF, and collagen levels
were significantly higher in the older subjects compared with the young
(Fig. 4C-E). Together, these and above data suggest that NOX4 con-
tributes to age-associated increase in aortic stiffness by both remodeling
the extracellular matrix as well as inducing intrinsic stiffness of VSMCs.
NOX4 Overexpression Induces Structural Changes Associated
with Aging, Impacting Aortic Elasticity and Volume Compliance.
Aortic stiffness is linearly correlated with subendothelial matrix elastic
modulus [35]. Hence, we measured the mechanical modulus of ab-
dominal aortas using pressure myography [36]. The aortic rings from
abdominal aortas of young Nox4TG618 mice showed a progressive and
significant left ward shift in stress-strain relationship compared with
aortic rings from the wild-type mice, indicating increased aortic
stiffness (Fig. 5A). However, aortic wall thickness and outer diameter
were not different between the two genotypes (Fig. 5 B and C). A sig-
nificant reduction in aortic volume compliance was observed in young
Nox4TG618 mice at physiological pressures (110 and 130mmHg)
compared with the age-matched wild-type mice (Fig. 5D).
Focal adhesions, which connect the cortical cytoskeleton of VSMCs
to the matrix in aortic wall, are an important regulator of aortic stiffness
[37] and NOX4 is implicated in focal adhesion stability [38]. To de-
termine whether focal adhesions play a role in aging-associated aortic
stiffness, we compared focal adhesion number and turnover in aortic
VMSCs of young wild-type and Nox4TG618 mice. As assessed by im-
munostaining for autophosphorylation of focal adhesion kinase (FAK)
on tyrosine 397, which increases under conditions associated with en-
hanced focal adhesion formation [39], Nox4TG618 VSMCs had sig-
nificantly higher number of focal adhesions compared with the wild-
type VSMCs (Fig. 5E). In addition, nocodazole-induced microtubule-
dependent focal adhesion turnover at 15 and 45min following noco-
dazole washout was significantly lower in Nox4TG618 VSMCs. Further
characterizing the structural changes in age-associated aortic stiffening,
we measured the expression of load-bearing protein collagen I [40]. As
shown in Fig. 5F, aortic collagen I levels were significantly increased in
young Nox4TG618 mice, mainly as a result of greater expression in the
adventitia. Hyaluronan expression is regulated by NADPH oxidases
Fig. 1. Generation and characterization of mitochondrial-
specific Nox4 transgenic mice. (A) Essential features of the
full length Nox4 overexpressing construct are depicted in the
cartoon. The Nox4 gene is preceded by a Chicken β-actin
promoter and a mitochondrial targeting sequence (B)
Southern blot analysis for estimation of Nox4 transgene copy
number in Nox4TG605 (low expresser) and Nox4TG618
(high expresser). Relative Nox4 gene copy number was as-
sessed by spiking the wild-type genomic DNA with 0.2, 2, 20
or 200 ng of the transfection plasmid containing full length
Nox4 gene. (C) Real-time reverse transcription polymerase
chain reaction analysis of Nox4 mRNA expression in aortic
VSMCs (mean ± SEM, N=6). (D) Western blot analysis of
NOX4 protein levels from liver mitochondria of the trans-
genic mice along with mitochondrial marker protein prohi-
bitin (left panel). Densitometric quantification of NOX4 le-
vels normalized to prohibitin levels (right panel;
mean ± SEM, N=4) (E). Representative confocal micro-
scopy images of VSMCs showing NOX4 localization to mi-
tochondria in wild-type, TG605, and TG618 mice. Cells were
stained with MitoTracker Green FM and rabbit anti-NOX4
and AlexaFluor 647 rabbit anti-goat IgG. Bright yellow
fluorescence indicates increased NOX4 levels in mitochon-
dria. (F). Data presented was integrated density of NOX4 and
MTG fluorescence (mean ± SEM, N = 30). Scale is 10 μm
*P < 0.05. (For interpretation of the references to colour in
this figure legend, the reader is referred to the Web version
of this article.)
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[41] and aortic stiffening was attributed to increased hyaluronan ac-
cumulation [42]. Analysis of hyaluronan expression, as measured by
immunoreactive hyaluronan binding protein levels, showed a marked
increase in aortic hyaluronan levels in Nox4TG618 versus wild-type
mice (Fig. 5G). Lastly, we examined aortic medial calcium deposition
by von Kossa staining as calcification increases aortic stiffening [12]. As
shown in Fig. 5H, aortic calcium deposition was significantly higher in
young Nox4TG618 versus wild-type mice. Together, these data support
the notion that increase in NOX4 levels, particularly in mitochondria,
play a major role in vascular aging.
Young Nox4TG Mice Show Elevated Aortic and VMSC
Mitochondrial H2O2 and Superoxide Production. To determine
whether vascular aging and aortic stiffness observed in Nox4TG mice is
mediated by increased oxidative stress, we first measured H2O2 pro-
duction, using Amplex Red assay, in abdominal aortic segments and
mitochondrial isolates from VSMCs. Aortic H2O2 levels increased 51
and 146% in Nox4TG605 and TG618 mice, respectively, compared with
the wild-type mice (Fig. 6A). Similarly, a significant and transgene
expression-dependent mitochondrial H2O2 production was observed in
VSMCs, with 37 and 76% increase in Nox4TG605 and TG618 mice,
respectively, compared with the wild-type mice (Fig. 6B).
Although NOX4 predominantly produces H2O2[9], NOX4 expres-
sion is also correlated with increased superoxide levels [16]. In line
Fig. 2. Young (4-month old) Nox4 transgenic mice with high mitochondrial NOX4 expression show increased aortic stiffness and reduced contractile function in aorta
and VSMCs. (A) Pulse wave velocity (PWV) was measured in wild-type, Nox4TG605, and Nox4TG618 mice (mean ± SEM, N = 5–8; *P < 0.05 versus Nox4TG605,
***P < 0.001 versus wild-type). Maximal contractile force in abdominal aortic rings in response to phenylephrine (PE, 3.16× 10−5M) was measured by wire
myography in (B) wild-type and Nox4TG605 and (C) wild-type and Nox4TG618 mice (mean ± SEM, N = 7; *P < 0.05). The force generation dose-response curves
for PE were shown for (D) wild-type and Nox4TG605 and (E) wild-type and Nox4TG618 aortic rings (mean ± SEM, N=7). (F and G) VSMC contraction was
measured using collagen gel-based contraction assay kit and the area of the dislodged gel was measured using NIH image J software (mean ± SEM; n = 6;
*P < 0.05).
Fig. 3. Aortic VSMCs from Nox4TG618 mice show increased cellular stiffness.
Histogram represents cellular stiffness (elastic modulus), measured by atomic
force microscopy, derived from cantilever deflection data for at least 10 VSMCs
per genotype (10 cells for each genotype; 150 observations for wild-type and
105 for TG618). The solid curves are a fit to a normal distribution. Inset shows
the mean elastic modulus± SEM. *P < 0.05. The atomic force microscopy
measurements were repeated with two more aortic VSMC isolates and with
similar results.
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with this, transgene expression-dependent increase in mitochondrial
superoxide levels, as measured by MitoSOX Red fluorescence, was ob-
served in medial VSMCs in aortic cross sections of young Nox4TG mice
compared with the wild-type mice (Fig. 6C). Cellular superoxide levels,
as determined by DHE fluorescence, increased significantly in medial
VSMCs of Nox4TG618 compared with the Nox4TG605 and wild-type
mice (Fig. 6C). Similarly, transgene expression-dependent increase in
mitochondrial and cellular superoxide levels was observed in VSMCs
from Nox4TG mice compared with the wild-type mice (Fig. 6D). Rote-
none + antimycin A treatment markedly inhibited superoxide levels in
VSMCs from Nox4TG618 mice, suggesting that increased superoxide
levels were partly of mitochondrial origin (SI Appendix, Fig. S2). In-
hibition of superoxide levels in the presence of MitoTEMPO and PEG-
SOD in Nox4TG618 mouse aortic VSMCs further supports both mi-
tochondria-derived and Nox4 transgene-dependent increase in mi-
tochondrial superoxide levels (SI Appendix, Fig. S2). Together, these
data demonstrate that vascular oxidative stress was greater in aortas of
Nox4TG618 mice with higher Nox4 transgene expression.
Aortic VSMCs from Young Nox4TG Mice Show Increased DNA
Damage and Apoptosis. Multiple levels of evidence have established a
correlation between oxidative DNA damage and aging [12,14,43] and
increased mitochondrial oxidative stress drives aging-induced vascular
dysfunction via induction of apoptosis [44]. Hence, we investigated
whether increased mitochondrial NOX4 expression in young Nox4TG
mice induced oxidative DNA damage in aortic VSMCs. A 3.7-fold in-
crease in VSMCs with comet tails was observed in Nox4TG618 mice
compared with the wild-type mice (Fig. 7A). Although the number of
VSMCs with comet tails also increased in Nox4TG605 mice, the increase
was not significant compared with the wild-type mice. Congruent with
this, long PCR amplification of 10 kb mitochondrial DNA was 2.3-fold
lower in VSMCs of Nox4TG618 mice compared with Nox4TG605 and
wild-type mice, indicating an increase in DNA lesions that are blocking
mitochondrial DNA replication (Fig. 7B).
Furthermore, the expression of phosphorylated histone variant 2AX
(γH2AX), which accumulates at DNA double-strand breaks and recruits
DNA repair machinery [45], increased markedly in VSMCs from young
Nox4TG618 mouse compared with Nox4TG605 and wild-type mice
(Fig. 7C). In contrast, expression of the oxidative DNA base excision
repair enzyme, 8oxoG DNA glycosylase [46] (OGG1) was significantly
decreased in VSMCs from young Nox4TG618 mouse compared with
Nox4TG605 and wild-type mice (Fig. 7C). Similarly, the expression of
TFAM (transcription factor A, mitochondrial), which maintains mi-
tochondrial DNA stability by binding it to form nucleoids and stimu-
lating its replication [47] was greatly reduced in young Nox4TG618
mouse aortic VSMCs versus young wild-type mouse VSMCs (Fig. 7C). In
addition, expression of superoxide dismutase 2 (SOD2), the principal
scavenger of mitochondrial superoxide, was almost completely sup-
pressed in young Nox4TG618 mouse VSMCs (Fig. 7C). Interestingly,
TFAM and SOD2 expression were markedly upregulated in young
Nox4TG605 mouse VSMCs versus the wild-type cells, suggesting that a
moderate increase in NOX4 levels and hence, H2O2 levels over a rela-
tively short duration induce mitochondrial transcription factor and
antioxidant enzyme expression.
Next, we examined apoptosis in aortic sections by TUNEL-staining.
As shown in Fig. 7D, a significant transgene expression-dependent in-
crease in TUNEL+ medial SMC was observed in young Nox4TG605 and
Nox4TG618 mice versus wild-type mice. In consonance with this data, a
significant transgene expression-dependent increase in apoptosis was
observed in Nox4TG618 and TG605 VSMCs versus wild-type VSMCs in
culture (Fig. 7E). We also examined the expression of poly (ADP-ribose)
polymerase (PARP), a DNA-binding protein, which is a determinant of
cell viability in response to DNA damage [48], in aortic VSMCs with
and without Nox4 overexpression. As observed with TFAM and SOD2,
VSMCs from young Nox4TG605 mice had a marked increase in PARP
Fig. 4. Increase in NOX4 expression is associated
with vascular fibrosis in young Nox4TG mice and
older human subjects. Representative images of
mouse aortic sections stained for immunoreactive
connective tissue growth factor (A, CTGF, green,
red=elastin autofluorescence, scale 100 μm) and
stained with picrosirius red (B, scale 100 μm). CTGF
levels (A, bottom panel) and picrosirius red staining
(B, bottom panel) presented as integrated density
(mean ± SEM, N=5–10). Representative carotid
artery sections from young and old subjects stained
for immunoreactive NOX4 (C, brown, scale 500 μm)
and CTGF (D, red, scale 500 μm) and stained with
picrosirius red (E, scale 500 μm). NOX4 (C, bottom
panel) and CTGF levels (D, bottom panel) and pi-
crosirius red staining (E, bottom panel) presented as
integrated density (mean ± SEM, N = 5–10).
*P < 0.05, **P < 0.01 and ***P < 0.001. (For
interpretation of the references to colour in this
figure legend, the reader is referred to the Web
version of this article.)
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expression versus wild-type cells, whereas PARP expression was un-
detectable in Nox4TG618 VSMCs in Western blots (Fig. 7F). The fact
that apoptosis is increased in Nox4TG605 versus wild-type cells sug-
gests that more than one mechanism for inducing apoptosis is active in
these cells.
Young Nox4TG Mice Show Increased Aortic VSMC Senescence
and Proinflammatory Gene Expression. DNA damage accrual impairs
tissue function and increases susceptibility to age-associated diseases by
inducing replicative senescence [43]. Also, induction of premature se-
nescence was reported in a number of cell types in response to oxidative
stress [49] and NOX4 activity is correlated with replicative senescence
in human umbilical vein endothelial cells [50]. Premature senescence,
assessed by staining for senescence-associated β-galactosidase (SA-β-
Gal) activity, increased significantly in young Nox4TG618 mice VSMCs
compared with Nox4TG605 and wild-type mouse cells (Fig. 8A). In
addition, cell proliferation as assessed by BrdU incorporation was 233%
lower in VSMCs from young Nox4TG618 mice compared with the wild-
type mice (Fig. 8B), indicating replicative senescence. The proliferation
of Nox4TG605 VSMCs was not significantly different from wild-type
cells.
In addition, VSMCs from young Nox4TG618 mice showed sig-
nificantly increased Ser 317 phosphorylation of CHK1 and decreased
Thr187 phosphorylation of p27Kip1, supporting replication arrest with
increased NOX4 expression (Fig. 8C) [51,52]. Inflammation is corre-
lated with arterial stiffness [53] and we have shown that NOX4 reg-
ulates vascular inflammation in aging [15]. As shown in Fig. 8 D and E,
the expression of transforming growth factor β1 (TGFβ1), a profibrotic
cytokine, was 1.88-fold higher (P < 0.05) in VSMCs from young
Nox4TG618 mice compared with the wild-type mice; Nox4TG605 mice
VSMCs also show higher TGFβ1 levels, but the difference was not sig-
nificant from the wild-type. Vascular cell adhesion molecule 1 (VCAM1)
is among the genes identified in polymorphism association studies with
a possible causal role in arterial stiffness [54]. In agreement with our
previous observations [12,15], VSMCs from young Nox4TG618 mice
with higher mitochondrial NOX4 levels had an approx. 56% increase
(P < 0.05) in VCAM1 expression compared with VSMCs from wild-
type and Nox4TG605 mice (Fig. 8 D and F). Together, these data sug-
gest that increased mitochondrial oxidative stress and DNA damage in
Fig. 5. Young Nox4TG618 mice show reduced
aortic elasticity and volume compliance and
structural changes associated with aging. Aortic
elasticity (A), wall thickness (B), outer diameter
(C), and volume compliance (D) were measured in
wild-type and Nox4TG618 mice using pressure
myograph (mean ± SEM, N=4). (E)
Representative images of VSMCs immunostained
for phosphorylated focal adhesion kinase with
FAKpY397 antibody (green) and counterstained
with DAPI (blue) in the presence and absence of
10 μM nocodazole (left panel). Inhibition of focal
adhesion turnover with increased NOX4 expres-
sion was quantified by FAKpY397 staining
(mean ± SEM, N=25; right panel). The experi-
ment was repeated twice with similar results. (F)
Representative immunofluorescence images of
aortic cross sections stained for type I collagen
(red, collagen I and blue, DAPI). Quantification of
collagen I expression shown as fluorescence in-
tegrated density (mean ± SEM, N=6). (G)
Representative immunohistochemistry (IHC) sec-
tions stained for hyaluronan binding protein
(HAB; top panel). Quantification of HAB expres-
sion shown as IHC grade (mean ± SEM, N=6;
lower panel). (H) Representative histochemistry
(HC) sections stained with von Kossa stain (top
panel). Quantification of calcium shown as HC
grade (mean ± SEM, N=6; lower panel). (For
interpretation of the references to colour in this
figure legend, the reader is referred to the Web
version of this article.)
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young Nox4TG618 mice phenocopy premature and replicative senes-
cence and increased vascular inflammation associated with aging which
contributes to aortic stiffening.
Increased NOX4 Expression Induces Mitochondrial Dysfunction
in Young Nox4TG Mice. We previously showed that increased ex-
pression/activity of mitochondrial NOX4 in aging was correlated with
decreased vascular respiratory chain complex activity and bioenergetics
[12]. Also, impaired mitochondrial respiration is a key factor in orga-
nismal functional decline and may result from and contribute to
Fig. 6. Increase in mitochondrial NOX4 protein levels is correlated with en-
hanced H2O2 and ROS levels in whole aortas and aortic VSMCs. (A) Aortic H2O2
levels were determined using Amplex Red assay and normalized to protein le-
vels (mean ± SEM, N=5). (B) VSMC mitochondrial H2O2 levels were de-
termined using Amplex Red assay. H2O2 levels are normalized to protein con-
centration and are the mean ± SEM of three independent experiments. (C)
Representative fluorescence microscopy images of aortic sections stained with
MitoSOX Red and MitoTracker Green FM. Bright yellow/orange fluorescence
indicates increased mitochondrial ROS generation in medial VSMCs. Scale is
100 μm. Data presented as integrated density of MitoSOX Red fluorescence
(mean ± SEM, N=5). Representative DHE fluorescence microscopy images
and quantification of DHE fluorescence in medial VSMCs (mean ± SEM,
N=5). Scale is 100 μm. (D) Representative fluorescence microscopy images of
VSMCs stained MitoSOX Red and MitoTracker Green FM. Bright yellow fluor-
escence indicates increased ROS generation. Data presented was integrated
density of MitoSOX Red fluorescence (mean ± SEM, N=30). Scale is 10 μm.
Representative DHE fluorescence microscopy images and quantification of DHE
fluorescence in VSMCs (mean ± SEM, N = 30). Scale is 10 μm *P < 0.05 and
**P < 0.01. (For interpretation of the references to colour in this figure legend,
the reader is referred to the Web version of this article.)
Fig. 7. Young Nox4TG mice show increased DNA damage and apoptosis in
VSMCs. (A) Representative comet assay images and quantification of cells with
comet tails in aortic VSMCs isolated from wild-type and Nox4TG mice. Percent
of cells with comets from 15 microscopic areas from three independent ex-
periments (mean ± SEM, N=3). (B) Representative long PCR amplicon
showing decreased 10 kb mitochondrial DNA in VSMCs from wild-type,
Nox4TG605, and Nox4TG618 mice. The amplified 16.5 kb mitochondrial
genome band intensity was normalized to a short PCR amplicon of 0.22 kb
GAPDH (mean ± SEM, N=3). (C) Representative Western blots of VSMC ly-
sates indicate more DNA damage and increased oxidative stress, as shown by
increased levels of γH2AX and decreased levels of OGG1, TFAM, and SOD2 in
Nox4TG618 versus Nox4TG605 and wild-type mice. (D) Representative fluor-
escent microscopy images of TUNEL-stained aortic sections showing increased
TUNEL+ nuclei in medial VSMCs of Nox4TG618 versus Nox4TG605 and wild-
type mice. Quantification of TUNEL+ nuclei (mean ± SEM, N=3). (E)
Representative fluorescent microscopy images of TUNEL-stained VSMCs
showing increased TUNEL+ nuclei in Nox4TG618 versus Nox4TG605 and wild-
type VSMCs. Quantification of TUNEL+ nuclei (mean ± SEM, N=3). (F)
Western blot analysis of PARP expression levels in aortic VSMCs of wild-type
and Nox4TG mice. Data shown are representative of three independent ex-
periments. *P < 0.05, **P < 0.01 and ***P < 0.001.
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increased H2O2 production [55]. VSMCs from young Nox4TG18 showed
a significant decrease in basal, ATP-driven, and maximal mitochondrial
oxygen consumption rate (OCR; P < 0.05) compared with VSMCs from
young wild-type and Nox4TG605 mice (Fig. 9 A-D). Bioenergetic ana-
lysis also showed significant decreases in mitochondrial reserve re-
spiratory capacity, uncoupled OCR and non-mitochondrial respiration
in Nox4TG18 VSMCs versus wild-type and Nox4TG605 VSMCs (Fig. 9
A-E). All the bioenergetic parameters analyzed were higher in
Nox4TG605 VSMCs versus wild-type cells, but the differences were not
significant. Correlating with decreased OCR data, citrate synthase ac-
tivities in Nox4TG618 VSMCs were significantly lower compared with
the Nox4TG605 and wild-type VSMCs (Fig. 9 F). Compensating the
diminished mitochondrial oxidative capacity, glycolysis increased sig-
nificantly in Nox4TG18 VSMCs versus the wild-type cells (P < 0.01;
Fig. 9 G). These data support a role for increased mitochondrial NOX4
levels in aging-associated mitochondrial dysfunction.
Young Nox4TG618 and mCAT Double Transgenic Show
Attenuated Aortic Stiffness. Rabinovitch and colleagues showed that
overexpression of human catalase in mitochondria attenuated ven-
tricular fibrosis and hypertrophy associated with myocardial stiffness in
old mice [56]. Similarly, attenuation of mitochondrial oxidative stress
by supplementation with MitoQ, a mitochondria-targeted antioxidant,
ameliorated aortic stiffening in old mice [57] and older adults [58]. The
loss of SOD2 expression increases the initial mitochondrial superoxide
levels in Nox4TG618 aortic medial VSMCs. The mitochondrial
Fig. 8. Increase in mitochondrial NOX4 protein level induces senescence and
pro-inflammatory marker expression in VSMCs. (A) Representative brightfield
microscope images of VSMCs stained for SA-β-Gal activity (upper panel) and %
SA-β-Gal-positive cells (lower panel, mean ± SEM, N=3). (B). VSMC pro-
liferation rate was determined by BrdU incorporation (representative bright-
field microscope images, upper panel) and the number of BrdU-positive cells
(lower panel) was assessed as described in Methods section (mean ± SEM,
N=3). Scale is 10 μm in A and B. (C) Representative Western blots showing
protein levels of replication arrest markers pCHK1 (phospho checkpoint kinase
1, Ser317) and pp27 (phospho KIP1, Thr187) in 60% confluent VSMCs. (D)
Representative Western blots showing protein levels of proinflammatory ma-
kers TGFβ1 and VCAM1. β-tubulin was used as a loading control in C and D.
Densitometric quantification of TGFβ1 (E) and VCAM1 protein levels normal-
ized to β-tubulin levels (F). *P < 0.05.
Fig. 9. Young Nox4 transgenic mice with high mitochondrial NOX4 expression
show reduced respiration in aortic VSMCs. (A) Oxygen consumption rate (OCR)
of aortic VSMCs isolated from wild-type, Nox4TG605, and Nox4TG618 mice
was determined using Seahorse XF-24 analyzer. VSMCs were plated at
25,000 cells/well in XF-24 plates and OCR was measured at the basal levels and
in the presence of 2 μM oligomycin, 500 nM trifluoromethoxy carbonylcyanide
phenylhydrazone (FCCP), and 0.5 μM antimycin A + 500 nM rotenone. Data
shown are mean ± SEM, N=3. Mitochondrial bioenergetic parameters de-
rived from OCR measurements are: (B) basal OCR, (C) uncoupled OCR, (D)
maximal OCR, and (E) respiratory reserve capacity (mean ± SEM, N=3). (F)
VSMC citrate synthase activity levels (mean ± SEM, N=3). (G) Extracellular
acidification rate (ECAR) of aortic VSMCs from the wild-type and Nox4TG618
mice was determined using Seahorse XFp analyzer. VSMCs were plated at
30,000 cells/well in XFp plates and ECAR was measured at the basal level (no
glucose) and in the presence of 10mM glucose and 1 μM oligomycin and the
data were normalized to protein concentration (mean ± SEM, N = 3).
*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.
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superoxide levels are further increased by mitochondrial NOX4-derived
superoxide [16]. However, superoxide spontaneously dismutates to
H2O2 quite rapidly in concentration-dependent manner. To confirm
that vascular aging in young Nox4TG618 is mediated by increased
mitochondrial oxidative stress, we measured PWV in young
Nox4TG618 mice with (Nox4TG618 x mCAT mice) and without over-
expression of mitochondria-targeted human catalase. Fig. 10A shows
overexpression of NOX4 and catalase in young Nox4TG618 x mCAT
double transgenic mice. PWV was significantly attenuated in young
double transgenic mice compared with young Nox4TG618 (Fig. 10B;
P < 0.001). Furthermore, comparison of dose response curves showed
that overexpression of catalase in mitochondria reversed the decreased
phenylephrine-induced contractile force generation in Nox4TG618
mice (Fig. 10C), thus confirming the role of mitochondrial NOX4 in
aging-associated impaired vasomotor function. Together, our present
and previous studies [12,22] show that mitochondrial oxidative stress is
a causal factor in aortic stiffness and vascular aging.
2. Discussion
This study presents evidence that increase in mitochondrial ROS,
from increased NOX4 expression/activity in mitochondria, is a causa-
tive factor in aging-associated aortic stiffening as young Nox4TG618
mice with mitochondrial targeted NOX4 overexpression phenocopy
aortic stiffening in aging. We confirmed increased Nox4 expression in
the transgenic mice by Southern blot and mRNA expression analyses,
increased NOX4 protein by Western blot analysis, and increased mi-
tochondrial NOX4 levels by confocal immunofluorescence. Our results
also show that mitochondrial ROS levels beyond the physiological
threshold level are necessary for aortic stiffening because young
Nox4TG605 mice with a twofold increase in mitochondrial ROS levels
do not show increased aortic stiffening.
The effect of higher NOX4 expression at the cellular level in vas-
culature was evident by increased VSMC mitochondrial and aortic H2O2
levels and enhanced cellular and mitochondrial superoxide levels in
isolated aortic VSMCs and in medial VSMCs in aortic cross sections,
establishing the role of increased NOX4-derived ROS in recapitulating
aging-associated aortic stiffening in young Nox4TG618 mice. That mi-
tochondrial oxidative stress is a key factor in age-associated aortic
stiffening is supported by our previous studies [12,22] and other studies
[23,57] in animal models. The potential clinical relevance of mi-
tochondrial oxidative stress in age-associated aortic stiffness is evident
in a randomized, placebo-controlled, double-blind, crossover design
pilot study by Seals and colleagues [58] which showed that chronic
supplementation with MitoQ significantly improved endothelium-de-
pendent brachial artery flow-mediated dilation and lowered aortic
stiffness and oxidized LDL levels in older adults.
Consistent with the data from classical studies of vascular me-
chanics that extracellular matrix is the major contributor to vessel wall
stiffness [59,60], increased mitochondrial oxidative stress in young
Nox4TG618 mice increased aortic stiffness as shown by stress-strain
curves; congruently, volume compliance was reduced. In addition, in-
creased mitochondrial ROS impaired phenylephrine-mediated aortic
contraction in young Nox4TG618 mice and collagen gel contraction
assay showed that decreased aortic contraction is mostly mediated by
mitochondrial oxidative stress-induced changes in the contractile phe-
notype of aortic SMCs, although decrease in overall medial cellularity
could contribute to impaired aortic contraction as well since
Nox4TG618 aortic cross sections show increase in TUNEL+ SMCs. It is
interesting that increased mitochondrial NOX4 expression, while im-
pairing aortic SMC contraction, has no effect on both endothelium-de-
pendent and independent vasorelaxation.
Our data show that young Nox4TG618 mice with increased aortic
stiffening had increased aortic collagen I expression, which renders
extracellular matrix more rigid [61]. Collagen I expression, higher in
the aortic media of transgenic mice, was more predominant in the ad-
ventitia and might reflect the transdifferentiation of adventitial fibro-
blasts to collagen synthesizing myofibroblasts in conditions of increased
mitochondrial stress as happens in aging. This is in agreement with a
previous report that arterial stiffening in aging is mediated by increased
adventitial collagen I induced by increased levels of TGFβ1 [62], a
NOX4 inducer [15].
Another contributing factor in the recapitulation of aging-associated
aortic stiffness in young Nox4TG618 mice is increased number of focal
adhesions and impaired focal adhesion turnover. Our data show
markedly increased number of focal adhesions as observed by increased
tyrosine 397 autophosphorylation and activation of focal adhesion ki-
nase (FAK) in Nox4TG618 aortic VSMCs [61]. The activated FAK is
bound by the SH2 domain of Src kinase and the activated FAK-Src
complex allows the phosphorylation of other focal adhesion proteins
[63]. Nocodazole removal induces microtubule repolymerization in
5–15min and maximal dissolution of focal adhesions at 30min [38].
The Nox4TG618 VSMC focal adhesions are resistant to nocodazole in-
duced dissolution, which is in line with a previous report that persistent
FAK-Src signaling complex of focal adhesions in non-migratory and
quiescent VSMCs in the vessel wall is a significant regulator of aortic
stiffness [37]. Normal aortic VSMC focal adhesions with an inherent
ability to regulate their maturation and connections to nonmuscle cy-
toskeleton accommodate changes in vessel stress and stiffness in young
mice [60]. In contrast, impaired VSMC focal adhesion dynamics with
dissolution resistant adhesions under increased mitochondrial oxidative
stress conditions compromise the ability of aorta and other large elastic
vessels to maintain vessel tone in response to changes in hemody-
namics. It is worth noting in this context that NOX4 localizes to and
H2O2 is produced in focal adhesions and is required for focal adhesion
stabilization, albeit in migrating VSMCs [38]. Also, the activity of small
GTPase RhoA, which is upstream of FAK activation in focal adhesion
formation, is activated by ROS produced by NOX438.
Young Nox4TG618 mice show increased nuclear and mitochondrial
DNA damage and premature and replicative senescence in aortic
Fig. 10. Overexpression of catalase targeted to mitochondria attenuates aortic
stiffness and contractile function in young Nox4TG mice. (A) Western blot
analysis of NOX4 and catalase expression in aortic lysates. (B) PWV was mea-
sured in mCAT (transgenic mice with overexpression of human catalase in
mitochondria), Nox4TG618, and Nox4TG618 x mCAT mice (mean ± SEM,
N = 6; ***P < 0.001, ****P < 0.0001; One-way ANOVA with Tukey's mul-
tiple comparison test). (C) The force generation dose-response curves for PE
were shown for Nox4TG618 and mCAT x Nox4TG618 aortic rings
(mean ± SEM, N = 7; *P < 0.05).
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VSMCs, which is in line with evidence that accrual of DNA damage
triggers cellular senescence and metabolic changes that impair tissue
function and increase susceptibility to age-related diseases [43]. In
addition, VSMCs from these mice show decreased OGG1 levels, in-
dicating impaired DNA repair capacity and TFAM levels, indicating
reduced mitochondrial biogenesis. Decreased TFAM levels could in-
crease ROS levels in a feed forward manner and induce senescence since
mitochondrial dysfunction caused by TFAM inactivation increased ROS
levels and induced cell cycle arrest, ultimately resulting in lethal car-
diomyopathy [64]. Although counterintuitive, another feed forward
mechanism for increased ROS levels with significantly higher mi-
tochondrial NOX4 levels in young Nox4TG618 mouse aortic VSMCs
could be the suppression of SOD2 expression. Ji et al. reported that
miR-146a, a widely expressed microRNA that is upregulated by H2O2,
interacts with Sod2 regulatory region and downregulates SOD2 protein
expression via a post-transcriptional regulation mechanism [65].
Several clinical studies have shown significantly higher aortic
stiffness in patients with several chronic inflammatory disorders and its
association with increasing tertiles of different inflammatory bio-
markers, including leukocyte and granulocyte count [66]. Increased
VCAM1 expression in young Nox4TG618 mouse aortic VSMCs might
enable extravasation of circulating leukocytes into the aortic wall, in-
creasing aortic stiffness. Interestingly, aortic stiffening was associated
with inflammation mediated adventitial collagen deposition by T cells
[67] and cytomegalovirus-specific senescent CD8+ T cells [68].
Our data showing attenuated aortic stiffness and improved aortic
contractility in young Nox4TG618 mice with mitochondrial-targeted
overexpression of catalase confirms the role of mitochondrial oxidative
stress in aging-associated aortic stiffness as reported previously by us
[12,22] and others [23,57,58]. Analogous amelioration of mitochon-
drial oxidative stress using mitochondrial antioxidant MitoTEMPO
significantly reduced aortic stiffness in aged hypercholesterolemic mice
[12]. Similarly, trehalose which enhances mitophagy and reduces ROS
levels and MitoQ reduced aortic stiffness in old mice but had no effect
in young mice [23]. Remarkably, oral supplementation with MitoQ for
a short period of 6 weeks significantly lowered aortic stiffness in older
adults in a pilot study [58], indicating the therapeutic potential of
targeting mitochondrial oxidative stress for the treatment of large ar-
tery stiffness.
In summary, our results provide evidence that increased mi-
tochondrial NOX4 levels have a causative effect on vascular aging by
inducing intrinsic VSMC stiffness, extracellular matrix remodeling,
aortic calcification and VSMC senescence, apoptosis, and inflammation
by increasing mitochondrial oxidative stress. Because aortic stiffness is
associated with several cardiovascular risk factors such as smoking,
diabetes mellitus, dyslipidemia, and hypertension and is a major con-
tributor to cardiovascular events, preventing and treatment of aortic
stiffness by preserving mitochondrial homeostasis, either via targeting
NOX4 expression/activity or using mitochondrial antioxidants, may be
a viable new therapeutic option for age-related CVD.
3. Materials and Methods
Mice. All procedures were performed in compliance with protocols
approved by the University of Michigan Institutional Animal Care and
Use Committee in accordance with NIH guidelines. To generate NOX4
transgenic mice, the transgene DNA consisting of the CAG promoter
(chicken beta-actin promoter with cytomegalovirus early enhancer)
driving the mouse Nox4 expression cassette preceded by a mitochondria
targeted sequence of human cytochrome C oxidase was injected into
pronuclei of C57BL/6 embryos and implanted into pseudo-pregnant
foster female mice. The resulting offspring were analyzed for the in-
sertion of the transgene construct and the founder lines with single
transgene integration were identified by Southern blot analysis. The
mouse genomic DNA was digested with BsrG1 and hybridized with a
probe to the CMV enhancer of the transgene. A standard curve was
developed using increasing concentrations of Nox4 transgene plasmid
DNA (0.2, 2, 20 and 200 ng). The founders were crossed with wild-type
C57BL/6J mice to establish independent breeding lines. University of
North Carolina Animal Models Core Facility performed transgene
cloning, embryo microinjection and founder Southern blot analysis. The
Nox4 transgene-positive offspring were identified by PCR using fol-
lowing primers: 5Ꞌ-TTCGGCTTCTGGCGTGTGAC-3Ꞌ and 5Ꞌ-CAACATTT
GGTGAATGTAGTAGTATTCTGGC-3Ꞌ. All breeder lines were back-
crossed with C57BL/6J mice for 10 generations and lines with low
(TG605) and high (TG618) Nox4 expression levels were identified by
qPCR and Western blot analysis. TG618 were crossed with mCAT
transgenic mice (mouse with expression of human catalase gene in
mitochondria; The Jackson Laboratory, stock #016197) to generate
Nox4 x mCAT double transgenic mice. Mice were housed in ventilated
cages at 22oC with a 12 h light/dark cycle, with free access to food and
water and male mice were used in all the experiments.
VSMCs isolation and culture. Vascular smooth muscle cells
(VSMCs) were isolated from aortas of 4 month-old wild-type,
Nox4TG605 and Nox4TG618 male mice and cultured as described
previously [12]. All experiments were performed using VSMCs that
were growth arrested 72 h in DMEM supplemented with 0.1% FBS and
were from passages 3–11.
Single cell gel electrophoresis (comet assay). Comet assay was
performed using 1000 mouse VSMCs as described in SI Materials and
Methods.
Mitochondrial DNA damage assay. VSMC mitochondrial DNA
damage was assessed as described in SI Materials and Methods.
Immunofluorescence/Immunohistochemistry. DHE and
MitoSOX Red fluorescence measurements for detection of superoxide
and immunohistochemistry of VSMCs, mouse aortas, and human car-
otid arteries were performed as described previously [12] and in SI
Materials and Methods.
BrdU incorporation assay. BrdU incorporation into VSMCs was
performed as described in SI Materials and Methods.
SA-β-galactosidase assay. Senescence-associated β-gal staining in
VSMCs was performed using cellular senescence staining kit (Cell
Biolabs, Inc.) as described in SI Materials and Methods.
Amplex Red assay. H2O2 generation was measured using the
Amplex® Red Hydrogen Peroxide Assay Kit (Invitrogen) as described
previously [12] and in SI Materials and Methods.
Collagen gel contraction assay. Cell contraction was measured
using a collagen gel based contraction assay kit (Cell Biolabs, Inc.) as
described in SI Materials and Methods.
Mitochondrial bioenergetics assay. Mitochondrial bioenergetics
were evaluated using the.
Seahorse XF-24 extracellular flux analyzer (Seahorse Biosciences) as
described previously [12] and in SI Materials and Methods.
Analysis of cellular glycolysis. VSMC glycolysis levels were de-
termined as described in SI Materials and Methods.
Citrate synthase activity assay. VSMC citrate synthase activity
was analyzed as described in SI Materials and Methods.
Western blotting. Western blot analysis was performed as de-
scribed previously [12] and in SI Materials and Methods.
Pulse wave velocity (PWV). PWV measurements were per-
formed by the Physiology Phenotyping Core at the University of
Michigan. The mice were anesthetized with 1–1.5% isoflurane/O2
mixture to maintain a surgical plane of anesthesia and were placed on a
warming pad to maintain body temperature at 37oC. ECG was mon-
itored via non-invasive resting ECG electrodes. Pulse wave velocity
between the thoracic and abdominal aorta was measured utilizing high
temporal resolution of ECG-Gated Kilohertz Visualization (EKV) ima-
ging using Visual Sonics Vevo 2100 high resolution in vivo micro-ima-
ging system. Pulse wave velocity was calculated by dividing the arterial
distance between these points, estimated using a measuring tape, and
the time delay for the pulse, calculated based on the ECG.
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3.1. Functional analysis of vascular reactivity
Wire myography. The vascular reactivity of aortic rings was ana-
lyzed by wire myography as described in SI Materials and Methods.
3.2. Determination of vascular mechanics
Pressure myography. Aortic stress-strain relationship and volume
compliance were analyzed by pressure myography as described in SI
Materials and Methods.
Focal adhesion turnover assay. VSMCs were grown to 60% con-
fluence and were quiesced for 72 h in DMEM supplemented with 0.1%
FBS. The cells were incubated with or without nocodazole (10 μM) for
2 h to depolymerize microtubules and thus dissolve the focal adhesions.
The nocodazole was washed and cells were incubated in DMEM with
0.1% FBS to allow the reformation of focal adhesions for either 15 or
45min. The cells were fixed with 4% paraformaldehyde and permea-
bilized with 0.05% Triton X-100. The cells were then stained for im-
munoreactive focal adhesion kinase (FAKpY397) primary antibody and
an AlexaFluor secondary antibody to measure FAK specific immuno-
fluorescence.
Measurement of VSMC stiffness with atomic force microscopy
(AFM). AFM measurements of VSMC stiffness were performed by
the Single Molecule Analysis in Real-Time (SMART) Center at the
University of Michigan. AFM images and force-distance (F-D) traces
were acquired on a TT-AFM (AFMWorkshop, Signal Hill, CA) in contact
mode in DMEM buffer with CSG01 probes (TipsNano, Tallinn, Estonia).
Approximately 5–15 F-D curves were acquired per cell (serum-starved
for 3 days), sampling many regions from each cell. AFM probe sensi-
tivity was calibrated from F-D curves acquired on glass. Cantilever
spring constant was estimated using the Sader method [69].
The F-D curves were fit assuming a pyramidal tip shape and a
Poisson ratio of 0.5 to extract the Young's modulus using AtomicJ
software [70]. The contact point of the F-D curve was estimated
manually, and only the first 1 μm of deflection fit to estimate the
stiffness of the cell without interference from the underlying glass
substrate. Outliers more than 3 standard deviations above the mean
were discarded.
Human carotid arteries. Human carotid artery segments were
obtained through National Disease Research Interchange (NDRI). These
samples were collected during autopsy 10–12 h postmortem. The
postmortem subjects ranged in age from 21 to 89 years and included
both male and female. The young subjects had an average age of
36.7 ± 6.28 (n= 18) and old 65.2 ± 12.8 (n= 46). All human car-
otid artery samples were deidentified and their use was approved by the
University of Michigan Institutional Review Board. Samples from NDRI
had incomplete medical history on comorbidities and prescription
drugs.
Statistics. All biochemical experiments were conducted at least
three times. Where applicable, 2-tailed Student's t-test was performed
for significance. In other cases, where three groups are compared si-
multaneously, one-way ANOVA was performed with Bonferroni's post-
hoc test. Differences were considered significant at P < 0.05.
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